News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Yüksel Ürün: Updated 1st-line treatment in mRCC!
Photo from Yüksel Ürün/X
Apr 23, 2024, 23:49

Yüksel Ürün: Updated 1st-line treatment in mRCC!

Yüksel Ürün, Doctorate Professor at the Faculty of Medicine, Ankara University, Turkey, shared a post on X:

“Updated first-line treatment in metastatic renal cell carcinoma (mRCC)!”

Yüksel Ürün: Updated 1st-line treatment in mRCC!

Source: Yüksel Ürün/X

 

cancer metastatic renal cell carcinoma mRCC OncoDaily Oncology treatment Yüksel Ürün
Blog
Aug 14, 2024, 03:01
Mary Schubauer-Berigan on what new evidence was reviewed when evaluating the carcinogenicity of talc - IARC
Insight
Aug 14, 2024, 02:52
Andreina Fernandes: A new era of cervical cancer
Insight
Aug 14, 2024, 02:45
Shahrin Ahmed: The use of machine learning for the diagnosis of prostate cancer
Insight
Aug 14, 2024, 02:35
Nehemias Guevara-Rodriguez: Our abstract about lung cancer screening was accepted at ASCOQLTY24
Insight
Aug 14, 2024, 02:22
Elvina Almuradova: Increased Breast Cancer Risk in Women with POI
Insight
Aug 14, 2024, 02:11
Felipe Couñago: Analyzing diagnostic and treatment wait times for lung cancer Patients
Insight
Aug 14, 2024, 01:53
5 papers about lung cancer suggested by Stephen Liu
Insight
Aug 13, 2024, 20:25
Hidehito Horinouchi: Impact of Durvalumab on corticosteroid therapy for pneumonitis after chemoradiotherapy
Insight
Aug 13, 2024, 20:14
Ane Gerda Zahl Eriksson: Molecular characterization of early stage grade 3 endometrial adenocarcinoma
Blog
Aug 13, 2024, 20:06
What happens when our community comes together to help - Fred Hutchinson Cancer Center
Blog
Aug 13, 2024, 19:48
Julie McCrossin AM: I am frustrated at the delay in Australians getting access to proton therapy for oropharyngeal cancer
Insight
Aug 13, 2024, 19:38
Aakash Desai: MYC IHC could be crucial in tailoring immunotherapy approaches in NSCLC